Correlation Between Infection Status of Epstein-Barr Virus and F-Fluorodeoxyglucose Uptake in Patients with Advanced Gastric Cancer

Overview

Journal In Vivo

Specialty Oncology

Date 2017 Jun 28

PMID 28652452

Citations 4

Authors

Sae Jung Na

Hye Lim Park

Joo Hyun O

Sung Yong Lee

Kyo Young Song

Sung Hoon Kim

Affiliations

Soon will be listed here.

Abstract

Background: Epstein-Barr virus-associated gastric cancer (EBVaGC) is one of the four molecular subtypes of gastric cancer, as defined by the classification recently proposed by The Cancer Genome Atlas. We evaluated the correlation between EBV positivity and F-fluorodeoxyglucose (F-FDG) uptake by positron emission tomography/computed tomography (PET/CT) in patients with gastric cancer.

Materials And Methods: We retrospectively enrolled patients with gastric cancer who underwent pretreatment F-FDG PET/CT and subsequent surgical resection, and then were diagnosed with advanced gastric cancer (pathologic stage ≥T2 with any N stage). Maximum standardized uptake values (SUV) of gastric cancer were measured by pretreatment F-FDG PET/CT. EBV sequences were detected by in situ hybridization (ISH) techniques. We analyzed the correlation between EBV positivity, clinicopathologic features and metabolic activity of the primary tumor.

Results: A total of 205 patients were included and 15 (7.3%) patients were identified as having EBV-positive gastric cancer. Age, gender, tumor location, and histological type showed no significant differences between EBV-positive and negative groups. EBV-positive cancer is significantly more frequent in the higher-metabolic-tumor group than in the lower one (p=0.032). The mean SUV of gastric cancers showed significant differences between EBV-positive and negative groups (9.9±4.2 vs. 7.0±4.8, p=0.026).

Conclusion: The infection status of EBV was significantly related to the F-FDG uptake of primary tumors in patients with advanced gastric cancer.

Citing Articles

The role of MAPK pathway in gastric cancer: unveiling molecular crosstalk and therapeutic prospects.

Yuan W, Shi Y, Dai S, Deng M, Zhu K, Xu Y J Transl Med. 2024; 22(1):1142.

PMID: 39719645 PMC: 11667996. DOI: 10.1186/s12967-024-05998-8.

Investigating the relationship between Epstein-Barr virus infection and gastric cancer: A systematic review and meta-analysis.

Dokanei S, Minai-Tehrani D, Moghoofei M, Rostamian M Health Sci Rep. 2024; 7(3):e1976.

PMID: 38505684 PMC: 10948593. DOI: 10.1002/hsr2.1976.

Promising Response to Lenalidomide-Combination Therapy in a Discordant Lymphoma Consisting of EBV-Positive Diffuse Large B-Cell Lymphoma and Angioimmunoblastic T-Cell Lymphoma: A Case Report.

Hu P, Ben Y, Liu J, Zheng W, Yan X, Zhang Y Onco Targets Ther. 2021; 14:2489-2495.

PMID: 33883903 PMC: 8053605. DOI: 10.2147/OTT.S297539.

Association between Epstein-Barr virus infection and gastric cancer: a systematic review and meta-analysis.

Tavakoli A, Monavari S, Solaymani Mohammadi F, Kiani S, Armat S, Farahmand M BMC Cancer. 2020; 20(1):493.

PMID: 32487043 PMC: 7268387. DOI: 10.1186/s12885-020-07013-x.

References

Lopci E, Toschi L, Grizzi F, Rahal D, Olivari L, Castino G . Correlation of metabolic information on FDG-PET with tissue expression of immune markers in patients with non-small cell lung cancer (NSCLC) who are candidates for upfront surgery. Eur J Nucl Med Mol Imaging. 2016; 43(11):1954-61. DOI: 10.1007/s00259-016-3425-2. View

Na S, O J, Park J, Lee H, Lee S, Song K . Prognostic value of metabolic parameters on preoperative 18F-fluorodeoxyglucose positron emission tomography/ computed tomography in patients with stage III gastric cancer. Oncotarget. 2016; 7(39):63968-63980. PMC: 5325418. DOI: 10.18632/oncotarget.11574. View

Lee J, Lee S, Lee M, Shin H . Role of ¹⁸F-FDG PET/CT in the prediction of gastric cancer recurrence after curative surgical resection. Eur J Nucl Med Mol Imaging. 2012; 39(9):1425-34. DOI: 10.1007/s00259-012-2164-2. View

Sukawa Y, Yamamoto H, Nosho K, Kunimoto H, Suzuki H, Adachi Y . Alterations in the human epidermal growth factor receptor 2-phosphatidylinositol 3-kinase-v-Akt pathway in gastric cancer. World J Gastroenterol. 2012; 18(45):6577-86. PMC: 3516204. DOI: 10.3748/wjg.v18.i45.6577. View

Zhang J, Jia L, Lin W, Yip Y, Lo K, Lau V . Epstein-Barr Virus-Encoded Latent Membrane Protein 1 Upregulates Glucose Transporter 1 Transcription via the mTORC1/NF-κB Signaling Pathways. J Virol. 2017; 91(6). PMC: 5331802. DOI: 10.1128/JVI.02168-16. View

Wu Z, Zhao J, Gao P, Song Y, Sun J, Chen X . Prognostic value of pretreatment standardized uptake value of F-18-fluorodeoxyglucose PET in patients with gastric cancer: a meta-analysis. BMC Cancer. 2017; 17(1):275. PMC: 5392988. DOI: 10.1186/s12885-017-3271-z. View

Fukayama M, Ushiku T . Epstein-Barr virus-associated gastric carcinoma. Pathol Res Pract. 2011; 207(9):529-37. DOI: 10.1016/j.prp.2011.07.004. View

Camargo M, Murphy G, Koriyama C, Pfeiffer R, Kim W, Herrera-Goepfert R . Determinants of Epstein-Barr virus-positive gastric cancer: an international pooled analysis. Br J Cancer. 2011; 105(1):38-43. PMC: 3137422. DOI: 10.1038/bjc.2011.215. View

Camargo M, Kim W, Chiaravalli A, Kim K, Corvalan A, Matsuo K . Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis. Gut. 2013; 63(2):236-43. PMC: 4384434. DOI: 10.1136/gutjnl-2013-304531. View

10.

Kuzushima K, Nakamura S, Nakamura T, Yamamura Y, Yokoyama N, Fujita M . Increased frequency of antigen-specific CD8(+) cytotoxic T lymphocytes infiltrating an Epstein-Barr virus-associated gastric carcinoma. J Clin Invest. 1999; 104(2):163-71. PMC: 408473. DOI: 10.1172/JCI6062. View

11.

Wu M, Shun C, Wu C, Hsu T, Lin M, Chang M . Epstein-Barr virus-associated gastric carcinomas: relation to H. pylori infection and genetic alterations. Gastroenterology. 2000; 118(6):1031-8. DOI: 10.1016/s0016-5085(00)70355-6. View

12.

Liu X, Liu J, Qiu H, Kong P, Chen S, Li W . Prognostic significance of Epstein-Barr virus infection in gastric cancer: a meta-analysis. BMC Cancer. 2015; 15:782. PMC: 4619309. DOI: 10.1186/s12885-015-1813-9. View

13.

van Beek J, Zur Hausen A, Snel S, Berkhof J, Kranenbarg E, van de Velde C . Morphological evidence of an activated cytotoxic T-cell infiltrate in EBV-positive gastric carcinoma preventing lymph node metastases. Am J Surg Pathol. 2005; 30(1):59-65. DOI: 10.1097/01.pas.0000176428.06629.1e. View

14.

. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011; 14(2):101-12. DOI: 10.1007/s10120-011-0041-5. View

15.

. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014; 513(7517):202-9. PMC: 4170219. DOI: 10.1038/nature13480. View

16.

Sugano H, Nakamura K, Kato Y . Pathological studies of human gastric cancer. Acta Pathol Jpn. 1982; 32 Suppl 2:329-47. View

17.

Alluri K, Tahari A, Wahl R, Koch W, Chung C, Subramaniam R . Prognostic value of FDG PET metabolic tumor volume in human papillomavirus-positive stage III and IV oropharyngeal squamous cell carcinoma. AJR Am J Roentgenol. 2014; 203(4):897-903. PMC: 4332840. DOI: 10.2214/AJR.14.12497. View

18.

Murphy G, Pfeiffer R, Camargo M, Rabkin C . Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location. Gastroenterology. 2009; 137(3):824-33. PMC: 3513767. DOI: 10.1053/j.gastro.2009.05.001. View

19.

Kang G, Lee S, Kim W, Lee H, Kim J, Rhyu M . Epstein-barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma. Am J Pathol. 2002; 160(3):787-94. PMC: 1867170. DOI: 10.1016/S0002-9440(10)64901-2. View

20.

Samuels Y, Wang Z, Bardelli A, Silliman N, Ptak J, Szabo S . High frequency of mutations of the PIK3CA gene in human cancers. Science. 2004; 304(5670):554. DOI: 10.1126/science.1096502. View